[go: up one dir, main page]

MX2008014395A - Composicion para el tratamiento de canceres resistentes que comprende oridonina. - Google Patents

Composicion para el tratamiento de canceres resistentes que comprende oridonina.

Info

Publication number
MX2008014395A
MX2008014395A MX2008014395A MX2008014395A MX2008014395A MX 2008014395 A MX2008014395 A MX 2008014395A MX 2008014395 A MX2008014395 A MX 2008014395A MX 2008014395 A MX2008014395 A MX 2008014395A MX 2008014395 A MX2008014395 A MX 2008014395A
Authority
MX
Mexico
Prior art keywords
treatment
oridonin
resistant
composition
present
Prior art date
Application number
MX2008014395A
Other languages
English (en)
Inventor
Sophie Chen
Original Assignee
Activephyto Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Activephyto Technologies Ltd filed Critical Activephyto Technologies Ltd
Publication of MX2008014395A publication Critical patent/MX2008014395A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere al tratamiento de neoplasias resistentes a terapia; los compuestos y métodos de la invención son particularmente útiles para el tratamiento de cánceres humanos resistentes a taxol, particularmente cánceres de cuello uterino y de mama; los componentes de las composiciones de la presente invención muestran sinergia fuerte unos con otros, lo que les permite usarse en cantidades relativamente bajas para el tratamiento de cáncer de etapa IV o recurrente que puede haber crecido resistente a los agentes quimioterapéuticos tradicionales; estas composiciones comprenden oridonina.
MX2008014395A 2006-05-11 2007-05-10 Composicion para el tratamiento de canceres resistentes que comprende oridonina. MX2008014395A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0609386.8A GB0609386D0 (en) 2006-05-11 2006-05-11 Treating drug resistant cancers
PCT/GB2007/001720 WO2007132190A1 (en) 2006-05-11 2007-05-10 Composition for the treatment of resistant cancers comprising oridonin

Publications (1)

Publication Number Publication Date
MX2008014395A true MX2008014395A (es) 2009-04-23

Family

ID=36637342

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008014395A MX2008014395A (es) 2006-05-11 2007-05-10 Composicion para el tratamiento de canceres resistentes que comprende oridonina.

Country Status (15)

Country Link
US (1) US9089546B2 (es)
EP (1) EP2026780A1 (es)
JP (1) JP2009536635A (es)
KR (1) KR20090037395A (es)
CN (1) CN101495108B (es)
AU (1) AU2007251374A1 (es)
BR (1) BRPI0712788A2 (es)
CA (1) CA2651795A1 (es)
GB (1) GB0609386D0 (es)
IL (1) IL195039A0 (es)
MX (1) MX2008014395A (es)
NO (1) NO20085147L (es)
RU (1) RU2455002C2 (es)
SG (1) SG171583A1 (es)
WO (1) WO2007132190A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1994293A (zh) * 2006-08-18 2007-07-11 上海交通大学医学院附属瑞金医院 冬凌草甲素在制药中的应用
FR2944435B1 (fr) * 2009-04-17 2011-05-27 Sederma Sa Composition cosmetique comprenant de l'oridonine
WO2013049507A1 (en) 2011-09-30 2013-04-04 Perio Sciences, Llc Antioxidant compositions for treatment of inflammation or oxidative damage
CN102648956A (zh) * 2012-05-18 2012-08-29 漳州市中草药研究所 一种治疗乳腺癌的中草药制剂及其制备方法
WO2014047780A1 (zh) * 2012-09-25 2014-04-03 鼎泓国际投资（香港）有限公司 含有芹菜素及芹菜素类衍生物和冬凌草甲素及冬凌草甲素类衍生物的药物组合物及其应用
CN104434939B (zh) * 2014-11-14 2017-05-03 深圳大学 三七皂苷r7和冬凌草甲素减毒增效抗肿瘤药物组合物及其应用
WO2019005829A1 (en) * 2017-06-26 2019-01-03 Wayne State University METHODS AND COMPOSITIONS RELATING TO CANCER DEPENDENT ON HORMONE RECEPTORS
WO2019013607A1 (ko) * 2017-07-14 2019-01-17 한국생명공학연구원 Oct4 저해용 조성물 및 이의 용도
CN115645370A (zh) * 2018-11-16 2023-01-31 江苏恒瑞医药股份有限公司 一种包含parp抑制剂的药物组合物
KR102263396B1 (ko) * 2019-11-01 2021-06-10 가톨릭관동대학교산학협력단 이소리퀴리티제닌 유도체를 포함하는 골 질환의 예방 또는 치료용 약학적 조성물
CN111467367B (zh) * 2020-05-22 2021-08-17 陈炯 一种用于抑制肿瘤细胞生长的植物单体组合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476016A (en) * 1975-07-31 1977-06-10 Nippon Shinyako Co Ltd Pharmaceutical compositions having anti-tumour activity
IT1271301B (it) * 1994-12-20 1997-05-27 Indena Spa Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono
US20030035851A1 (en) * 2001-02-08 2003-02-20 Sophie Chen Anti-cancer agents and method of use thereof
US20050032882A1 (en) * 2002-03-06 2005-02-10 Sophie Chen Botanical extract compositions and methods of use
CN1220519C (zh) * 2002-08-26 2005-09-28 上海中耀生物科技有限公司 治疗前列腺癌的中药组合物及其制备方法和制药应用
DE10394175T5 (de) 2003-03-06 2006-08-03 The Medical Research and Education Trust, San Diego Zusammensetzung mit einem botanischen Extrakt mit Anti-Krebs- oder phytoöstrogener Aktivität, enthaltend Prenyflavonoide

Also Published As

Publication number Publication date
CN101495108B (zh) 2014-10-15
IL195039A0 (en) 2009-08-03
NO20085147L (no) 2009-02-09
EP2026780A1 (en) 2009-02-25
CA2651795A1 (en) 2007-11-22
CN101495108A (zh) 2009-07-29
KR20090037395A (ko) 2009-04-15
RU2455002C2 (ru) 2012-07-10
BRPI0712788A2 (pt) 2012-09-11
RU2008148833A (ru) 2010-06-20
AU2007251374A1 (en) 2007-11-22
US20100016420A1 (en) 2010-01-21
WO2007132190A1 (en) 2007-11-22
JP2009536635A (ja) 2009-10-15
SG171583A1 (en) 2011-06-29
US9089546B2 (en) 2015-07-28
GB0609386D0 (en) 2006-06-21

Similar Documents

Publication Publication Date Title
MX2008014395A (es) Composicion para el tratamiento de canceres resistentes que comprende oridonina.
CL2011000504A1 (es) Compuestos derivados de piridin-4-il-tiazol-2il-amida 2-amida-pirrolidin-1,2-dicarboxilico, inhibidores de quinasa de fosfatidil-inositol-3; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de un medicamento para el tratamiento del cancer.
MX2021006531A (es) Composicion que contiene arn para tratamiento de enfermedades tumorales.
DOP2009000178A (es) Formulaciones para el tratamiento del cancer
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
GT200600092A (es) Alargar el tiempo hasta la progresion de la enfermedad o la supervivencia de los pacientes de cancer
PA8719401A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
MX2019015200A (es) Compuestos de diarilhidantoina.
UY29803A1 (es) Derivados de adeninas, composiciones farmacéuticas conteniéndolos, procedimientos de preparación y aplicaciones
GT201100017A (es) Derivados de piridazina como inhibidores de smo
EP1951729A4 (en) OXYGEN-LINKED PYRIMIDINE DERIVATIVES
CR20110388A (es) Compuestos heterocíclicos y métodos de uso
ECSP109953A (es) Derivados de piridazinona
PE20070723A1 (es) Imidazopirazinas como inhibidores de quinasas dependientes de ciclina
CL2012001250A1 (es) Compuestos derivados de espirooxoindol, antagonista de la interaccion entre p53 y mdm2; composición farmacéutica que lo comprende; a un kit farmacéutico; uso en el tratamiento del cancer.
CL2012000248A1 (es) Compuesto conjugado de insulina; procedimiento de preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; kit farmaceutico; uso en el tratamiento de trastornos mediados por insulina.
TW200716141A (en) Compositions and methods for treatment for neoplasms
UY29469A1 (es) Compuestos sulfoximino-macrocíclicos y sus sales, composiciones farmacéuticas que comprenden dichos compuestos, métodos de preparación y usos de los mismos.
CL2020002604A1 (es) Ciertos compuestos de pladienolida y métodos de uso.
PA8806801A1 (es) Compuestos de amida como refuerzos de antivirales
UY31700A (es) Tiazolil-dihidro-indazoles
MX2010000223A (es) Compuestos de triazina novedosos para el tratamiento de cancer.
UY31143A1 (es) Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas
UY29417A1 (es) Agentes endoparasiticidas
MX2011006532A (es) Compuestos anticancerigenos.

Legal Events

Date Code Title Description
HH Correction or change in general